ContractLicense Agreement • April 26th, 2023 • Alkermes Plc. • Pharmaceutical preparations • New Jersey
In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by “[**]”) has been excluded from this exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed.
ContractLicense Agreement • April 26th, 2023 • Alkermes Plc. • Pharmaceutical preparations
In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by “[**]”) has been excluded from this exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed.
